Diabetes Channel
Topics
Medications
Quicklinks
Related Channels

Generic Metaglip

Generic Metaglip is sold under the name Glipizide and Metformin tablets, and is available in three different strengths: 2.5 mg/250 mg, 2.5 mg/500 mg, and 5 mg/500 mg. The FDA has assigned an "AB" rating to the drug, meaning that it is equivalent to the brand-name medication. However, generic Metaglip may contain other ingredients, such as fillers and dyes, which may cause problems for people with allergies.

Generic Metaglip: An Overview

Metaglip® (glipizide and metformin) is a prescription medication that has been licensed to treat type 2 diabetes. It is a combination medication containing glipizide (Glucotrol® or Glucotrol XL®) and metformin hydrochloride (Fortamet®, Glucophage®, Glucophage XR®, Glumetza®, or Riomet®).
 
Metaglip was first manufactured by Bristol-Myers Squibb Company. The patent for the drug has since expired, which means a generic Metaglip can now be produced.
 

Strengths of Generic Metaglip

Generic Metaglip is available in the following strengths:
 
  • Glipizide and Metformin 2.5 mg/250 mg tablets -- containing 2.5 mg glipizide and 250 mg metformin
  • Glipizide and Metformin 2.5 mg/500 mg tablets -- containing 2.5 mg glipizide and 500 mg metformin
  • Glipizide and Metformin 5 mg/500 mg tablets -- containing 5 mg glipizide and 500 mg metformin.
     

Who Makes Generic Metaglip?

Generic Metaglip is currently made by two companies: Teva Pharmaceuticals and Corepharma.
 
Diabetes Tips for Seniors

Metaglip Drug Info

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.